 Arab patients with inflammatory bowel diseases, IBD, have distinctive clinical characteristics compared to their Jewish counterparts. Arab patients tend to be younger at diagnosis, more likely to present with anal fissures, perianal obsesses, erythema nodosum, diabetes mellitus, obesity, liver cirrhosis, and male infertility. They also receive fewer immunosuppressants such as azathioprine or mercaptopurine, but are more likely to receive steroids. Additionally, Arab patients experience a lower overall mortality rate than Jewish patients. This article was authored by Naim Abu Freya, Nur Ilawa, Muhammad Abu Tilak, and others.